Drooid Logo
Back to today’s briefing

Story perspectives

FDA Criticized for Targeting Essential Chest Binders

2/20/2026

50 6 Full Breakdown

1 of 1

Story summary
  • The FDA faces criticism for targeting chest binder manufacturers, affecting transgender people relying on gender-affirming care.
  • Point of Pride reports ongoing demand for binders, with about 40 requests daily from low-income individuals.
  • Trans individual Sean Ebony Coleman says these regulations may push gender-affirming care underground, recalling past experiences with harmful DIY binding methods.
  • Advocates say binders are essential for mental health, despite potential discomfort.